• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 4. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 5. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Market Research and Analysis Report on 1-Methyl-2-(trichloroacetyl)imidazole (CAS No. 30148-23-3)

The compound 1-Methyl-2-(trichloroacetyl)imidazole, identified by the CAS number 30148-23-3, has garnered significant attention in the chemical and pharmaceutical industries due to its unique properties and potential applications. This report aims to provide a comprehensive analysis of the current market landscape, research advancements, and future prospects for this compound.

Recent studies have highlighted the role of 1-Methyl-2-(trichloroacetyl)imidazole in various chemical reactions, particularly in the synthesis of bioactive molecules. Its trichloroacetyl group imparts reactivity, making it a valuable intermediate in drug discovery and development processes. The compound has been explored for its potential in anti-cancer therapies, where it demonstrates selective cytotoxicity against cancer cells.

Market demand for 1-Methyl-2-(trichloroacetyl)imidazole is driven by its use in academic research and industrial applications. Key regions exhibiting high demand include North America, Europe, and Asia-Pacific, with emerging markets in China and India showing significant growth potential. The compound is widely sourced from global suppliers specializing in fine chemicals and intermediates for pharmaceuticals.

To meet the increasing demand, several manufacturers have optimized their production processes to ensure scalability and cost-effectiveness. Advanced synthetic methodologies, including catalytic asymmetric synthesis and microwave-assisted reactions, have been employed to enhance the purity and yield of the compound. These innovations are expected to further stimulate market growth.

In terms of regulatory considerations, 1-Methyl-2-(trichloroacetyl)imidazole must adhere to stringent safety and quality standards imposed by global regulatory bodies such as the FDA and EMA. Ongoing research focuses on evaluating its toxicity profiles and environmental impact to ensure compliance with sustainability practices.

Looking ahead, the market for 1-Methyl-2-(trichloroacetyl)imidazole is poised for expansion due to increasing investments in drug development pipelines targeting complex diseases. Collaborative efforts between academia and industry are anticipated to accelerate innovation and application development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)